AKBA

Investigation Alert: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc. and Encourages Investors Who Formerly Held Shares of Keryx Biopharmaceuticals (KERX) to Contact the Firm

Akebia Therapeutics Announces Presentations at ERA-EDTA Virtual Congress 2021

AKBA Stock Price: Over 13% Increase Pre-Market Explanation

Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis

These Reddit Penny Stocks Are Soaring Today, Are They Worth Buying?

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript

AKBA Stock: From $3.20 To Over $3.49 Pre-Market Explanation